The aforementioned nanotherapeutic products and their success in tumor-specific treatment suggest that nanotherapeutics are a hugely effective therapy for ovarian cancer. Together with standard chemotherapy, nanotherapeutic agents can be delivered to specific tumors. This type of cancer treatment may entail high acquisition costs but it is justified by its cost-effectiveness especially in ovarian cancer Bosetti Marneffe Vereeck 2013. The use of nanotechnology-based medicines in the Philippines will decrease the number of deaths but will likely cost higher due to the minimal use of nanotherapeutics as a cure for cancer in the country. Commercialization is recommended to lower the prices of nanotherapeutic products to be able to reach patients with lower economic status. The inclusion of nanotherapeutics in national healthcare programs will also help in decreasing personal economic costs in cancer treatment but it will take years of planning and a budget of over a billion pesos before it is approved by the government in the Philippine setting.